智通财经APP获悉,NanoViricides(NNVC.US)周四表示,该公司已经开始研发对抗猴痘病毒的药物。受此消息提振,截至发稿,NanoViricides周四美股盘前暴涨47.97%,报3.64美元。 NanoViricides是一家基于新型纳米药物平台开发高效抗病毒疗法... 网页链接
$NanoViricides(NNVC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-24-000843 Act: 34 Size: 5 MB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-044367 Act: 34 Size: 515 KB 网页链接
$NanoViricides(NNVC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-044352 Act: 33 Size: 15 KB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-024973 Act: 34 Size: 491 KB 网页链接
$NanoViricides(NNVC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-24-000048 Act: 34 Size: 5 MB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-005254 Act: 34 Size: 205 KB 网页链接
$NanoViricides(NNVC)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-123215 Act: 34 Size: 255 KB 网页链接
$NanoViricides(NNVC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-23-002484 Act: 34 Size: 4 MB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-23-114862 Act: 34 Size: 199 KB 网页链接
$NanoViricides(NNVC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-23-002146 Act: 34 Size: 7 MB 网页链接